This page lists all pharmaceutical reports related to the field of Metabolic & Hormonal Disorders. The reports include market research reports and pipeline analyses.
- The World Market for Prescription Orthopedic Drugs
- Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Diabetes and Diabetic Complications: Major World Markets
- Proteomics - Technologies, Markets and Companies
- Transdermal Drug Delivery - Technologies, Markets, and Companies
- Gene Therapy - technologies, markets and companies
- Biomarkers - technologies,markets and companies
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Over-the-Counter Diagnostic Products World Markets
- Disposable Syringe Markets
- Blood Glucose Testing and Diabetes Management
- Cannabinoid Market Forecasts & Analysis to 2012
- Early Toxicology: Markets and Approaches
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Cell-Based Assays for Drug Discovery
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- DYSLIPIDEMIA - Therapy Area Pipeline Report
- HYPERLIPEMIA - Therapy Area Pipeline Report
- ATHEROSCLEROSIS and CORONARY ARTERY DISEASE - Therapy Area Pipeline Report
- HYPERCHOLESTEROLEMIA - Therapy Area Pipeline Report
- DIABETIC NEUROPATHY - Therapy Area Pipeline Report
- Infertility - Therapy Area Pipeline Report
- MENOPAUSAL SYMPTOMS - Therapy Area Pipeline Report
- Treating Neuropathic Pain: A Global Study of Clinical Strategies
- CONTRACEPTION - Therapy Area Pipeline Report
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- Drug Delivery Technology: Revolutionizing Diabetes Treatment
- The World Diabetes Market, 2006-2025
- Pediatric Drugs - the Worldwide Market
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Men's Health: The World Market for Current and Emerging Drug Therapies
- Type II Diabetes: The 45+ Market in the United States for Drugs and Diagnostics
- Inhaled Insulin: A Market Briefing
- Gene Expression Profiling Markets
- How to Conduct Clinical Trials in China
- PAD Interventional Market Analysis: Angioplasty and Atherectomy
- Acute Limb Ischemia - A market of multiple therapies and multiple procedures
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Outsourcing in Drug Discovery
- World Wound Care Markets 2008 - Burns, Skin Ulcers, Surgical and Trauma Wounds
- Lipitor Market analysis and forecasts
- World Wound Care Markets 2008
- Osteoporosis & Bone Metabolism Disorders Market 2008-2023
- Glucose Testing Markets
- Ion Channel Trends 2008
- Kinase Screening & Profiling Trends 2008
- GPCR Screening & Profiling Trends 2008
- Women's Reproductive Disorders Therapeutics 2008-2018
- Critical Limb Ischemia: Western Europe Epidemiology
- Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
- Protein Therapeutics Markets - Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments
- Two pharmaceutical reports for the price of one - End of year offer
- Protein Therapeutics Markets: Antithrombins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines
- Womens Health: Worldwide Prescription Drug Markets
- Womens Health 2009: Worldwide Prescription Drug Markets
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2009
- World Diabetes Market Analysis, 2009-2023
- Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024
- Statins: The World Market, 2009-2024
- Stem Cells - World Analysis 2009-2024
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- The Global OTC Pharmaceutical Market 2009-2024
- In Vitro Diagnostics Market Analysis 2009-2024
- World Diabetes Market Analysis, 2009-2023
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
- Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
- Rx to OTC Switches 2009
- Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Osteoporosis - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of the Home Healthcare Equipment Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis
- World Ophthalmic Pharmaceutical Market 2010-2025
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Infusion Pump Markets (Large Volume, Ambulatory, Insulin, Enteral and Other Pumps)
- The World Market for Diabetes Treatments
- Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017
- Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017
- Osteoporosis - Pipeline Assessment and Market Forecasts to 2017
- Diabetes Care Devices Global Market Briefing to 2016
- US Pharmaceutical Market Outlook 2011-2021
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Diabetes Market to 2016 - Biguanides and Insulin Analogs will be the Largest Selling Anti-Diabetic Drugs
- Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market
- The Future of In Vitro and In Vivo Diagnostic Integration
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
- Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
- Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value
- Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018
- Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Uterine Fibroids Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Acromegaly and Gigantism Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Nonalcoholic Steatohepatitis (NASH) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Women’s Infertility Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Hyperparathyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Hyperthyroidism Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018
- Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Dysmenorrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Dyslipidemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018
